Evaluation of the therapeutic efficacy of injectable 5FU solution for basal cell carcinoma in patients referred to Loghman Hakim and Shohada-e Tajrish hospitals between 2020 and 2021

Phase 2

Recruiting

• Conditions: Basal cell carcinoma.; Basal cell carcinoma of skin of lip; C44.01

• Registration Number: IRCT20200205046380N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

People with BCC who are willing to participate in the study
People with BCC who can go to the clinic for visiting

Exclusion Criteria

Recurrent BCC
Very large BCC (larger than 2 cm)
BCC around the eyes
Patients with lymphoma or leukemia or immunodeficiency or in pregnant or lactating patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment the complete improvement or shrinkage of the lesion. Timepoint: Weekly until the healing of lesion or up to 6 weeks. Method of measurement: Observation and questionnaire.

Secondary Outcome Measures

Name	Time	Method
Evaluation of response to treatment based on initial size, anatomical location, pathology type, and duration of lesion formation and investigation the response to treatment based on age and gender. Timepoint: Weekly until the healing of lesion or up to 6 weeks. Method of measurement: Observation and questionnaire.